| Name | Title | Contact Details |
|---|
NoIR Laser Company is a South Lyon, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
In a complex healthcare world, Medline strives to help our customers achieve both clinical and financial success. We do that through a personalized approach to listen and better understand our customers` needs in an environment that tirelessly demands lower costs and better outcomes. We are both a manufacturer and distributor with 1,200 direct sales reps who are dedicated points of contact for customers across the continuum of care. Because of our capabilities and engagement with other clinical and industry thought leaders, we deliver the most robust product portfolio and patient-care solutions to help healthcare providers perform at their very best. Our responsiveness and commitment to advancing the health of healthcare is evident in our actions every day. This is who we are. This is why customers choose us as their trusted business partner.
Warner Tech-Care Products, Inc. is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Precision Optics Corporation has been a developer and manufacturer of advanced optical instruments since 1982. We design and produce high-quality medical instruments, micro optics and assemblies with sizes less than 1 millimeter, and other advanced optical systems. Our medical instrumentation line includes rigid laparoscopes, arthroscopes, sinuscopes, and a line of world-class 3-D endoscopes. We also design and build flexible fiber scopes with diameters as small as 5 microns with illumination for use in minimally invasive surgical procedures. We have a complete line of endocouplers with focal ranges from 20mm - 45mm and a parfocal zoom coupler with focal ranges from 20mm-37mm. We are registered to the ISO 9001:2008, ISO 13485:2003, CMDCAS Quality Standards, and comply with the FDA Good Manufacturing Practices and the European Union Medical Device Directive for CE marking of our medical products.
ValenTx was founded with the goal of treating some of the most pervasive health problems of our time: obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. Our approach is to create a non-surgical, endoluminal bypass device that builds on the success of established medical interventions, resulting in a highly effective and least-invasive therapy. Current treatments for these diseases include surgery, pharmacology, and medically supervised lifestyle management. The risks, costs, and in some cases poor efficacy of these treatments have hampered their broad adoption by patients, physicians, and payers alike. A truly unmet clinical need exists for a therapy that can deliver the efficacy obtained through surgery, but without the risks and costs associated with surgical intervention. The ValenTx endoluminal bypass therapy mimics the attributes of a Roux-en-Y gastric bypass and is implanted through a non-surgical, endoscopic procedure. This procedure does not require gastric stapling or permanent changes to the patient`s anatomy. The device is removable, replaceable and designed so that the physician could change the therapeutic profile, thereby optimizing the treatment towards the individual patient`s needs. ValenTx has developed a strong intellectual property portfolio, which lies at the foundation of this therapy. The company has successfully conducted a series of clinical studies demonstrating the viability, safety, and efficacy of the therapy.